Acal, Sherly B.

HRN: 29-44-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2026
CEFTRIAXONE 1G (VIAL)
08/06/2026
08/13/2026
IV
1g
Q24H
Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: